Press Releases

Feb 04, 2016 3:22am EST

CollPlant Reports Positive Final Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy

Dec 08, 2015 4:47am EST

CollPlant Reports Positive Interim Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy

Nov 30, 2015 3:39pm EST

CollPlant Reports Positive Final Trial Results for Vergenix®FG Wound Filler

Oct 07, 2015 11:04am EDT

CollPlant Announces Completion of Patient Recruitment for Clinical Trial of Vergenix™FG (Flowable Gel) for the Treatment of Chronic Wounds

Sep 08, 2015 11:47am EDT

CollPlant to Present Results of its Product for the Treatment in Tendinopathy, at the 4th TERMIS Congress Which Will Take Place in Boston

Jul 28, 2015 3:45am EDT

CollPlant Names Shomrat Shurtz Senior Director of Business Development

Jul 20, 2015 4:01am EDT

CollPlant Reports Positive Interim Trial Results for Vergenix™STR, for the Treatment of Tendinopathy

Jul 13, 2015 4:00am EDT

CollPlant Executes Non-binding Term Sheet to Develop and Commercialize a Novel Product for Spinal Fusion and Trauma Indications in Collaboration with Leading US Partner

Mar 19, 2015 8:57am EDT

CollPlant Reports Positive Interim Trial Results for Vergenix®FG Wound Healing Gel

Mar 10, 2015 12:15pm EDT

CollPlant Appoints Ira Leiderman and Nira Dror to its Board of Directors